Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Choice follows the target area and the structure of the program
Proper handling and storage protocols should be followed
Because Retatrutide is a GLP-1-class agonist, the well-established class safety warnings apply as reference context: Thyroid C-cell tumors / MTC (boxed-warning class effect): GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors based on rodent data
Seek immediate medical attention if you experience: bloody or black stools, severe abdominal pain, signs of significant dehydration (no urine output for 8+ hours, rapid heart rate, confusion), fever above 101F (38.3C), or diarrhea lasting more than 7 consecutive days without improvement
Presented for research literature review only Chen C et al
FDA-tested stability data supports longer timelines
